Red Flags Detected

• ⚠ Dual Class Share Structure (new) — Tempus has a dual-class structure with Class B shares carrying 30 votes per share, all held by Mr. Lefkofsky, concentrating control.
• ⚠ Controlled Company (new) — Tempus is a controlled company under Nasdaq rules, so post-merger Personalis stockholders may lack standard corporate governance protections.
• ⚠ Combined Company Debt (new) — The combined company will carry about $1.4 billion in long-term debt, including $750 million convertible notes due 2030, which may limit financial flexibility.
• ⚠ Termination Fee (new) — Personalis may be obligated to pay Tempus a termination fee of $76.8 million if the merger agreement is terminated under certain circumstances.
• ⚠ Lower Floor Price Termination Right (new) — Personalis can terminate the merger if Tempus's stock price falls below $46.00 per share, and Tempus's stock has already traded below this level on several occasions since the merger announcement.
• ⚠ Auditor Scope Limitation (new) — Tempus's auditor PwC excluded acquired companies Ambry Genetics and Paige.AI from its internal control assessment for 2025, meaning the effectiveness of internal controls for those acquired businesses was not evaluated.